Showing 13 posts of 853 posts found.

NICE rejects arthritis drug Orencia

November 2, 2007
Sales and Marketing NICE

NICE has rejected Orenica, a new treatment for rheumatoid arthritis, saying the drug is not a cost effective option for …

Eisai to appeal against Alzheimer’s court ruling

October 3, 2007
Alzheimer's, Eisai, NICE

Eisai and Pfizer are to try once again to reverse NICE restrictions on Alzheimer’s drugs by appealing against the recent …

NICE approves MSD and Schering-Plough’s Ezetrol

September 14, 2007
Sales and Marketing Inegy, NICE, cv

NICE has approved Merck Sharp & Dohme and Schering-Plough's Ezetrol, but recommended the cheapest version be used – effectively blocking …

NICE to re-think blindness drugs decision

August 9, 2007
Sales and Marketing AMD, Lucentis, Macugen, NICE

NICE will delay issuing final guidance on two blindness drugs after an unprecedented patient outcry over its decision to block …

Woman wins court battle for Avastin treatment

July 19, 2007
Sales and Marketing NICE, avastin

A woman with bowel cancer has won her High Court battle for access to the drug Avastin, overturning a decision …

NICE set to block blindness drugs

June 15, 2007
Sales and Marketing AMD, Lucentis, Macugen, NICE

Most patients in England and Wales will be denied access to drugs for the leading cause of sight loss if …

NICE in the dock: what the judicial review means for pharma

April 16, 2007
Research and Development, Sales and Marketing NICE, UK, healthcare, judicial review

The National Institute for Health and Clinical Excellence (NICE) has been at the centre of controversy ever since its inception …

Exubera approval limited to needle-phobic patients

January 26, 2007
Sales and Marketing Exubera, NICE, Pfizer, diabetes, inhaled insulin

 Diabetes patients who are genuinely needle-phobic will be among the few to be given Pfizer’s inhaled insulin product Exubera on …

NICE to say no to Tarceva

November 17, 2006
Sales and Marketing NICE, Tarceva

Roche's new lung cancer treatment Tarceva looks set to be refused recommendation from NICE.Tarceva (erlotinib) is the first next-generation treatment …

Pharma’s evolving relationship with NICE

November 1, 2006
Research and Development, Sales and Marketing NHS, NICE, approval process, fast track, healthcare

Back when New Labour was only halfway through its first term of office and when the Millennium Bug was feared …

Head-to-head: Nice and the SMC

August 16, 2006
Research and Development, Sales and Marketing NICE, SMC, healthcare

The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the  Herceptin …

The way forward for clinical research

October 23, 2003
Research and Development NICE, clinical research, healthcare

Clinical investigators in drug development have made enormous contributions to the advancement of healthcare over the last 25 years, and …

The management of schizophrenia

October 14, 2003
Sales and Marketing NICE, clinical guidelines, healthcare, schizophrenia

The publication of NICE's clinical guidelines on the management of schizophrenia in December marks a significant milestone – the first …

Latest content